Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus

被引：0

作者：

Y. H. Walter

D. I. Spratt

S. Garreffa

J. F. McLeod

机构：

[1] Clinical Pharmacology,

[2] Novartis Pharmaceuticals Corporation,undefined

[3] 59 Route 10,undefined

[4] East Hanover,undefined

[5] New Jersey 07936,undefined

[6] USA e-mail: james.mcleod@pharma.novartis.com Tel.: +1-973-7815999; Fax: +1-973-7818865,undefined

[7] Maine Medical Center,undefined

[8] Portland,undefined

[9] Maine,undefined

[10] USA,undefined

来源：

European Journal of Clinical Pharmacology | 2000年 / 56卷

关键词：

Key words Type-2 diabetes mellitus; Nateglinide; Insulin secretion;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objectives: Pharmacodynamic effects of nateglinide, a novel antidiabetic agent, were investigated in patients with type-2 diabetes mellitus.

引用

页码：129 / 133

页数：4

共 50 条

[1] Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus
Walter, YH
Spratt, DI
Garreffa, S
McLeod, JF
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (02) : 129 - 133
[2] Mealtime glucose regulation in type 2 diabetes
Tuomilehto, J
Del Prato, S
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (06) : 380 - 383
[3] Nateglinide therapy for type 2 diabetes mellitus
Levien, TL
Baker, DE
Campbell, RK
White, JR
ANNALS OF PHARMACOTHERAPY, 2001, 35 (11) : 1426 - 1434
[4] Nateglinide atone and in combination with metformin improves glycemic control by reducing mealtime glucose spikes in type 2 diabetes
Horton, E
Clinkingbeard, C
Gatlin, M
Mallows, S
DIABETES, 2000, 49 : A112 - A112
[5] Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes
Horton, ES
Clinkingbeard, C
Gatlin, M
Foley, J
Mallows, S
Shen, S
DIABETES CARE, 2000, 23 (11) : 1660 - 1665
[6] Multiple effects of Nateglinide on glucose metabolism in obese patients with type 2 diabetes mellitus
Nishimura, H
Shintani, M
Maeda, K
Okuda, J
Tanaka, S
DIABETES, 2002, 51 : A609 - A609
[7] Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose spikes in Type 2 diabetes
Horton, E
Clinkingbeard, C
Gatlin, M
Mallows, S
DIABETOLOGIA, 2000, 43 : A186 - A186
[8] Glycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus
Palumbo, PJ
MAYO CLINIC PROCEEDINGS, 2001, 76 (06) : 609 - 618
[9] Mealtime glucose regulation with nateglinide in healthy volunteers - Comparison with repaglinide and placebo
Kalbag, JB
Walter, YH
Nedelman, JR
McLeod, JF
DIABETES CARE, 2001, 24 (01) : 73 - 77
[10] Management of type 2 diabetes mellitus - Defining the role of nateglinide
Carswell, CI
Culy, CR
Perry, CM
DISEASE MANAGEMENT & HEALTH OUTCOMES, 2002, 10 (06) : 363 - 383

← 1 2 3 4 5 →